Novo Nordisk reported DKK33.76B in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Bausch Health Companies USD 776M 287M Jun/2026
Bristol-Myers Squibb USD 299M 3.26B Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Merck USD 840M 2.72B Jun/2026
Novartis USD 4.73B 549M Jun/2026
Novo Nordisk DKK 33.76B 25.86B Jun/2026
Novo Nordisk DKK 5.25B 60.42B Jun/2026
Pacira USD 9.96M 5.33M Jun/2026
Sanofi EUR 1.12B 811M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026